Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
13F
13D/G
Other
|
|
Global Cord Blood Corp (CO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/29/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 08/11/2023 |
NT 20-F
| Form NT 20-F - Notification of inability to timely file Form 20-F: |
| 06/02/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
| 02/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/03/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/03/2023 |
SC 13G
| Pacific Alliance Group Ltd reports a 7.8% stake in Global Cord Blood Corporation |
| 12/02/2022 |
6-K
| Quarterly results |
| 10/31/2022 |
6-K
| Quarterly results |
| 10/21/2022 |
6-K
| Quarterly results |
| 09/26/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:|
Docs:
|
"FORM 6-K",
"Order of the Grand Court of the Cayman Islands",
"Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands HONG KONG, China, September 26, 2022 - Global Cord Blood Corporation , China’ s leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that an order was made by the Grand Court of the Cayman Islands on September 22, 2022 appointing Margot MacInnis and John Royle of Grant Thornton Specialist Services Limited and Chow Tsz Nga Georgia of Grant Thornton Recovery & Reorganisation Limited as the Joint Provisional Liquidators of the Company . Upon the making of the Order, the powers of the directors of the Company are suspended. Blue Ocean Structure Investment Company Limited, a sha..." |
|
| 09/23/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 67.1% stake in GLOBAL CORD BLOOD CORPORATION |
| 08/24/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 67.1% stake in GLOBAL CORD BLOOD CORPORATION |
| 08/16/2022 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
| 08/02/2022 |
NT 20-F
| Form NT 20-F - Notification of inability to timely file Form 20-F: |
| 07/06/2022 |
6-K
| Quarterly results |
| 07/05/2022 |
6-K
| Quarterly results |
| 06/27/2022 |
6-K
| Quarterly results |
| 06/22/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 67.1% stake in GLOBAL CORD BLOOD CORPORATION |
| 06/16/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 67.1% stake in GLOBAL CORD BLOOD CORPORATION |
| 06/16/2022 |
6-K
| Quarterly results |
| 06/15/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 67.1% stake in GLOBAL CORD BLOOD CORPORATION |
| 06/03/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 67.1% stake in GLOBAL CORD BLOOD CORPORATION |
| 05/31/2022 |
SC 13D/A
| Golden Meditech Stem Cells Co Ltd reports a 64.9% stake in Global Cord Blood Corporation |
| 05/27/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 65.4% stake in GLOBAL CORD BLOOD CORPORATION |
| 05/23/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 65.4% stake in GLOBAL CORD BLOOD CORPORATION |
| 05/23/2022 |
SC 13D
| Golden Meditech Stem Cells Co Ltd reports a 64.9% stake in Global Cord Blood Corporation |
| 05/20/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 65.4% stake in GLOBAL CORD BLOOD CORPORATION |
| 05/13/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 65.4% stake in GLOBAL CORD BLOOD CORPORATION |
| 05/09/2022 |
SC 13D/A
| Blue Ocean Structure Investment Co Ltd reports a 65.4% stake in GLOBAL CORD BLOOD CORPORATION |
| 04/29/2022 |
6-K
| Quarterly results |
| 02/28/2022 |
6-K
| Quarterly results |
| 02/15/2022 |
SC 13G/A
| JAYHAWK CAPITAL MANAGEMENT, L.L.C. reports a |
| 12/16/2021 |
6-K
| Quarterly results |
| 12/07/2021 |
6-K
| Quarterly results |
|
|
|